Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTED.L Regulatory News (TED)

  • There is currently no data for TED

Changes to Board and Committee Composition

28 Jul 2022 14:36

RNS Number : 1392U
Ted Baker PLC
28 July 2022
 

 

 

Ted Baker Plc

(the "Company")

 

Changes to Board and Committee Composition

 

Ted Baker Plc today confirms the departure of Andrew Jennings as director of the Company. This announcement is made in compliance with section 430(2B) of the Companies Act 2006.

 

As previously announced on 17 December 2021, Andrew Jennings did not seek re-election to the Board at the Annual General Meeting on 28 July 2022. Andrew Jennings' directorship of the Company ceased on 28 July 2022. 

 

Andrew Jennings received his fees as a director to the date of termination and no other payments will be made.

 

Save as set out above, Andrew Jennings will not receive any other compensation or payment for ceasing to be a director. 

 

These terms are in line with the Company's shareholder-approved remuneration policy.

 

Helena Feltham, Interim Chair, said:

"On behalf of the Board, I would like to thank Andrew for his strong leadership, passion, and commitment during his 8 years at Ted. In addition to his role as Remuneration Committee Chair, we have hugely valued his global retail and merchant experience and the continuity he has provided to the board following the death of John Barton." 

 

Andrew Jennings said:

"I am thrilled to have been part of this unique British heritage brand over the latter 8 years. I wish Helena Feltham, the Board and the Management team much success in implementing the critically important turnaround strategy over the next 18 months in line with the changing customer needs".

 

Ted Baker also announces the following committee changes have been agreed:

Nominations Committee

Remuneration Committee

Audit & Risk Committee

Fumbi Chima

-

-

Member

Jon Kempster

-

Chair

-

Meg Lustman

Member

Member

-

 

As a result of these changes, the composition of the Board committees is:

Nominations Committee

Remuneration Committee

Audit & Risk Committee

Helena Feltham

Chair

Member

Member

Fumbi Chima

-

-

Member

Jon Kempster

Member

Chair

Chair

Meg Lustman

Member

Member

-

 

As previously noted, Helena Feltham assumed the role of Interim Chair on 6 December 2021. This temporary role is in addition to her existing responsibilities as Senior Independent Director, Chair of the Nominations Committee, member of the Audit Committee and member of the Remuneration Committee.

 

While we had made good progress on the search for a new Chair, on 18 March 2022, Sycamore Partners Management LP announced that it was considering a possible offer for the Company and we consequently announced on 4 April 2022 that we had commenced a formal sale process. The Board considered that continuity and experience was key to the Company successfully negotiating this period, and we accordingly paused the search for a new Chair pending the outcome of the formal sale process.

 

The Board notes the recommendations of the Financial Reporting Council's UK Corporate Governance Code as regards the role of the Chair of the Board. In particular, the Board is mindful of the recommendations that the Chair should not chair the Nominations Committee when it is dealing with the appointment of their successor, and that the Chair of the Board should not be a member of the Audit Committee. Notwithstanding the Code provisions, the Board does not propose to make any further changes to Helena's roles and responsibilities during the temporary period while she is acting as Interim Chair.

 

The Board believes that, as Chair of the Nominations Committee, Helena has the necessary experience to be responsible for appointment of a new Chair of the Board. As Helena does not wish to be considered as a candidate for the permanent position of Chair and is committed to a smooth and quick transition to a new Chair at the appropriate time, the Board does not consider there to be a conflict of interest. Should any conflict of interest arise, Helena will recuse herself from the relevant discussions. Additionally, the Board believes that any other short-term changes to Board committees to align the composition with the recommendations of the UK Corporate Governance Code would be disruptive and would not be in the best interests of the Company at a time when ensuring continuity is paramount.

 

 

 

 

 

For further information contact:

Tulchan Communications

Tel: +44 (0) 20 7353 4200

Jonathan Sibun / Jessica Reid

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAXVLFLLDLXBBZ
Date   Source Headline
2nd Sep 20163:07 pmRNSTotal Voting Rights
12th Aug 201611:55 amRNSDirector/PDMR Shareholding
3rd Aug 20162:03 pmRNSTotal Voting Rights
29th Jul 20163:34 pmRNSDirector/PDMR Shareholding
8th Jul 201610:30 amRNSDirector/PDMR Shareholding
22nd Jun 20164:40 pmRNSHolding(s) in Company
15th Jun 20164:46 pmRNSDirector/PDMR Shareholding
14th Jun 20162:39 pmRNSResult of AGM
14th Jun 20167:00 amRNSTrading Update
2nd Jun 201611:18 amRNSTotal Voting Rights
27th May 20168:30 amRNSNotice of Trading Update
18th May 20162:58 pmRNSNotice of AGM
9th May 201612:09 pmRNSHolding(s) in Company
6th May 20161:04 pmRNSNotification of Transactions of Directors/Persons
25th Apr 20166:24 pmRNSHolding(s) in Company
20th Apr 20162:41 pmRNSHolding(s) in Company
17th Mar 20167:00 amRNSAnnual Results
15th Mar 20163:48 pmRNSHolding(s) in Company
15th Mar 20163:43 pmRNSHolding(s) in Company
1st Mar 201610:48 amRNSTotal Voting Rights
19th Jan 20164:42 pmRNSDirector/PDMR Shareholding
19th Jan 20164:34 pmRNSTotal Voting Rights
13th Jan 20167:00 amRNSTrading Update
8th Jan 20162:55 pmRNSNotice of Trading Update
6th Jan 20167:00 amRNSAcquisition of Property
24th Dec 201512:40 pmRNSSecond Price Monitoring Extn
24th Dec 201512:35 pmRNSPrice Monitoring Extension
17th Dec 20157:00 amRNSAcquisition of Property
19th Nov 20157:00 amRNSInterim Management Statement
10th Nov 201510:10 amRNSNotice of Interim Management Statement
6th Oct 20157:00 amRNSInterim Results
8th Sep 201511:29 amRNSNotice of Interim Results
12th Jun 20152:28 pmRNSResult of 2015 Annual General Meeting
12th Jun 20157:00 amRNSInterim Management Statement
10th Jun 201511:10 amRNSHoldings in Company
8th May 20157:00 amRNSAnnual Report & Accounts and Notice of AGM
1st May 20157:00 amRNSNotification of transactions of Directors/Persons
19th Mar 20157:00 amRNSAnnual Results
10th Mar 201510:08 amRNSSmaller Related Party Transaction
19th Feb 20157:00 amRNSNotice of Investor and Analyst Event
2nd Feb 20157:00 amRNSTotal Voting Rights
13th Jan 201510:22 amRNSCompletion of Placing
13th Jan 20157:00 amRNSProposed Placing
8th Jan 20157:00 amRNSTrading Update
5th Jan 20151:48 pmRNSNotice of Trading Statement
18th Nov 20141:41 pmRNSDirector/PDMR Shareholding
13th Nov 20147:00 amRNSInterim Management Statement
31st Oct 201411:47 amRNSNotice of Results
31st Oct 20147:00 amRNSLitigation Update
2nd Oct 20147:00 amRNSInterim results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.